Shamsi Abbasalizadeh

Shamsi Abbasalizadeh

Auto-generated profile, based on publicly available information

Shamsi Abbasalizadeh

Women’s Reproductive Health Research Center, Tabriz University of medical sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2019 in BMC Urology
Verified
Journal Article
Open access
PDF file
MAMilad Azami
Milad Azami
ZJZahra Jaafari
Zahra Jaafari
MMMansour Masoumi
Mansour Masoumi
MSMasoumeh Shohani
Masoumeh Shohani
GBGholamreza Badfar
Gholamreza Badfar
SAShamsi Abbasalizadeh
Shamsi Abbasalizadeh
Urinary tract infection (UTI) is a common clinical problem in pregnant women. Bacteriuria in pregnancy without antibiotic treatment could result in complications. This study aims to investigate the etiology and prevalence of UTI and asymptomatic bacteriuria (ASB) in pregnant women in Iran. This meta-analysis follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. To avoid bias, all steps of the study were carried out independently by two researchers. We conducted a comprehensive search on all the related literature in national databases, including IranDoc, SID, Barakat Knowledge Network System, RICST, Magiran, Iranian National Library and international databases, including Scopus, Embase, Science Direct, PubMed/ Medline, Cochrane Library, Web of Sciences, EBSCO, as well as Google Scholar search engine until June 2018. After considering the inclusion/exclusion criteria and qualitative evaluation, studies were analyzed based on random effects model using Comprehensive Meta-Analysis Software Version 2. In 31 studies with a sample size of 20,309, the prevalence of ASB in pregnant Iranian women was estimated to be 8.7% (95%CI: 7.2–10.4). The lowest and highest prevalence of ASB were observed in the third trimester (6.1% [95%CI: 2.1–16.4]) and first trimester (11.7% [95%CI: 7.9–16.9]), respectively. Subgroup analysis of the prevalence of ASB based on geographical region (P = 0.002) and province (P < 0.001) was significant but for the quality of studies (P = 0.51) was not significant. In 17 studies including 48,731 pregnant women, the prevalence of UTI was estimated to be 9.8% (95%CI: 7.6–12.5). The test for subgroup differences of prevalence of UTI for province (P < 0.001) was significant but for geographical region (P = 061) and quality of studies (P = 0.11) was not significant. Meta-regression model for the prevalence of UTI and ASB in pregnant women in Iran based on year of the studies was significant (P < 0.001). The most common microorganism involved in the etiology of UTI (61.6% [95%CI: 51.6–70.7]) and ASB (63.22% [95%CI: 51.2–73.8]) was E. coli. UTI and ASB are prevalent in pregnant women in Iran. Therefore, UTI screening is essential in pregnant women. The most common microorganism involved in the etiology of UTI and ASB in pregnant women in Iran is E.coli.

1 January 2019
Verified
Journal Article
Open access
PDF file
MAMilad Azami
Milad Azami
GBGholamreza Badfar
Gholamreza Badfar
ZKZahra Khalighi
Zahra Khalighi
PQParvin Qasemi
Parvin Qasemi
MSMasoumeh Shohani
Masoumeh Shohani
SAShamsi Abbasalizadeh
Shamsi Abbasalizadeh
Background: The association between anemia and postpartum depression (PPD) has been reported to be controversial in different studies. Therefore, this study aimed to provide a comprehensive assessment of anemia and PPD. Methods: This review study was conducted according to the MOOSE protocol and results have been reported according to the PRISMA ...

11 October 2017 in Current Diabetes Reviews
Verified
Journal Article
Closed access
PDF file
ARAziz H. Rad
Aziz H. Rad
SAShamsi Abbasalizadeh
Shamsi Abbasalizadeh
SVShabnam Vazifekhah
Shabnam Vazifekhah
FAFatemeh Abbasalizadeh
Fatemeh Abbasalizadeh
THTohid Hassanalilou
Tohid Hassanalilou
Leila KhaliliLeila Khalili
Leila Khalili
Background: Diabetes mellitus, a condition of multifactorial origin, is related to the intestinal microbiota by numerous molecular mechanisms. Controlling the vast increase in the prevalence of diabetes needs a natural and safe solution. Probiotics, known as live microorganisms that exert health benefits to the host, have anti-diabetic property. Objective: This review will highlight the current evidences in probiotic effectiveness and future prospects for exploring probiotic therapy in the prevention and control of diabetes. Methods: We searched Pub Med and Science Direct by using “Probiotics” and “Diabetes” for searching the studies aiming the application of probiotics and the beneficial effects of probiotics in diabetes prevention and control. Results: It has been shown that probiotics can increase insulin sensitivity and reduce autoimmune responses by modulating intestinal microbiota and decreasing the inflammatory reactions and oxidative stress. Recent evidences show that probiotics influences the host through modulating intestinal permeability and mucosal immune response, manipulating eating behaviors by appetite-regulating hormones and controlling gut endocannabinoid (eCB) system that is believed to be associated with inflammation and diabetes. Moreover, modulating the intestinal microbiota by probiotics controls host metabolism by affecting energy extraction from food and by biochemically converting molecules derived from the host or from gut microbes themselves. Conclusion: Experimental and clinical evidences support the hypothesis that the modulation of the gut microbiota by probiotics could be effective in prevention and management of diabetes.

11 October 2017 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
MSMahdieh Seifi
Mahdieh Seifi
SAShamsi Abbasalizadeh
Shamsi Abbasalizadeh
SMSakineh Mohammad‐Alizadeh‐Charandabi
Sakineh Mohammad‐Alizadeh‐Charandabi
LKLaleh Khodaie
Laleh Khodaie
MMMojgan Mirghafourvand
Mojgan Mirghafourvand

5 October 2017 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
SHSevil Hakimi
Sevil Hakimi
FFFaranak Farhan
Faranak Farhan
AFAzizeh Farshbaf-Khalili
Azizeh Farshbaf-Khalili
PDParvin Dehghan
Parvin Dehghan
YJYousef Javadzadeh
Yousef Javadzadeh
BKBagher Khalvati
Bagher Khalvati

1 January 2017 in International Journal of Women's Health and Reproduction Sciences
Verified
Journal Article
Closed access
MAMilad Azami
Milad Azami
MNMarzieh Parizad Nasirkandy
Marzieh Parizad Nasirkandy
AMAkram Mansouri
Akram Mansouri
ZDZahra Darvishi
Zahra Darvishi
SRshoboo rahmati
shoboo rahmati
SAShamsi Abbasalizadeh
Shamsi Abbasalizadeh